<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jofin</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал инфектологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Infectology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-6732</issn><publisher><publisher-name>IPO “АIDSSPbR"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22625/2072-6732-2009-1-2,3-58-63</article-id><article-id custom-type="elpub" pub-id-type="custom">jofin-260</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Пероральная регидратационная терапия при острых кишечных инфекциях</article-title><trans-title-group xml:lang="en"><trans-title>Oral rehydration therapy of acute enteric infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захаренко</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zacharenko</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>8 (812) 292-34-33</p></bio><email xlink:type="simple">zsm1@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Военно-медицинская академия им. С.М. Кирова, Санкт-Петербург</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Military-medical academy of С.М. Kirov, St.-Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>22</day><month>09</month><year>2014</year></pub-date><volume>1</volume><issue>2,3</issue><fpage>58</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Захаренко С.М., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Захаренко С.М.</copyright-holder><copyright-holder xml:lang="en">Zacharenko S.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.niidi.ru/jofin/article/view/260">https://journal.niidi.ru/jofin/article/view/260</self-uri><abstract><p>Анализ особенностей проведения регидратационной терапии при острых кишечных инфекциях в гражданских и военных лечено-профилактических учреждениях показал, что в гражданских центрах этот вид терапии назначался 84,5% больных, а в военных – 50,16%. Средняя продолжительность пероральной регидратации составила 4,0 суток при легкой степени тяжести, при средней – 5,3 и при тяжелом течении – 5,7 суток. В среднем при легком течении заболевания пациенты получали 1423,7 мл жидкости, при среднем – 1092,6 мл при тяжелом – 1652,2 мл. Соотношение больных, получавших только пероральные регидратационные растворы, к больным, получавшим только инфузионную терапию и к получавшим оба вида терапии, составило 1 : 6,8 : 2,4. Официнальные препараты составили 62% от всех назначений, чаще всего использовали регидрон (47,7%) и ОРС (16,5%).</p></abstract><trans-abstract xml:lang="en"><p>Analysis of holding rehydration therapy in acute intestinal infections in both civilian and military care facilities showed that the civilian centers of this type of therapy was appointed by 84,5% of patients, and in the military – 50,16%. The average duration of oral rehydration therapy was 4,0 days at the easy degree of weight, at middle – 5,3 and at a heavy flow – 5,7 days. On average, in easy degree of weight, patients received 1423.7 ml of liquid, at middle – 1092.6 ml at and a heavy flow - 1652.2 ml. Value for patients receiving only oral rehydration solution to patients who received only the infusion therapy and to receive both types of therapy was 1: 6,8: 2,4. Officinal drugs accounted for 62% of all appointments, often used Rehydron (47,7%) and ORS (16,5%).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острые кишечные инфекции</kwd><kwd>регидратационная терапия</kwd><kwd>регидратирующие растворы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute enteric diseases</kwd><kwd>rehydration therapy</kwd><kwd>infusion therapy</kwd><kwd>oral rehydration salt</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.cdc.gov/nczved/</mixed-citation><mixed-citation xml:lang="en">http://www.cdc.gov/nczved/</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mead, P.S. Food-related illness and death in the United States / P.S. Mead // Emerg. Infect. Dis. – 1999. – 5: 607–625.</mixed-citation><mixed-citation xml:lang="en">Mead, P.S. Food-related illness and death in the United States / P.S. Mead // Emerg. Infect. Dis. – 1999. – 5: 607–625.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Snyder, J.D. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data / J.D. Snyder, M.H. Merson // Bulletin of the World Health Organization, 1982, 60: 605–613.</mixed-citation><mixed-citation xml:lang="en">Snyder, J.D. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data / J.D. Snyder, M.H. Merson // Bulletin of the World Health Organization, 1982, 60: 605–613.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Claeson, M., Merson M.H. Global progress in the control of diarrheal diseases / M. Claeson, M.H. Merson // Pediatric Infectious Diseases Journal, 1990, 9: 345–355.</mixed-citation><mixed-citation xml:lang="en">Claeson, M., Merson M.H. Global progress in the control of diarrheal diseases / M. Claeson, M.H. Merson // Pediatric Infectious Diseases Journal, 1990, 9: 345–355.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Victora, C.G. Reducing deaths from diarrhoea through oral rehydration therapy / C.G. Victora [et al.] // Bulletin of the World Health Organization, 2000, 78: 1246–1255.</mixed-citation><mixed-citation xml:lang="en">Victora, C.G. Reducing deaths from diarrhoea through oral rehydration therapy / C.G. Victora [et al.] // Bulletin of the World Health Organization, 2000, 78: 1246–1255.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Oral rehydration salts: production of the new ORS. –World Health Organization, 2006.</mixed-citation><mixed-citation xml:lang="en">Oral rehydration salts: production of the new ORS. –World Health Organization, 2006.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
